The quasispecies diversity of RNA viruses is mainly determined by the fidelity of RNAdependent RNA polymerase (RdRp) during viral RNA replication. Certain amino acid residues play an important role in determining the fidelity, and such residues can be substituted with other amino acids to produce virus strains with higher fidelity. In this study, two amino acid substitutions (A283T and H421Y) in the RdRp of porcine reproductive and respiratory syndrome virus (PRRSV) were identified under the selection of ribavirin. Preliminary data showed that two substitutions were involved in conferring PRRSV with the properties of increased ribavirin resistance and restricted quasispecies diversity. The results indicated that these two amino acid residues (Ala283 and His421) play a crucial role in PRRSV replication by affecting the fidelity of its RdRp. The results have important implications for understanding the molecular mechanism of PRRSV evolution and pathogenicity, and developing a safer modified live-attenuated vaccine (MLV) against PRRSV.
RNA viruses evolve rapidly due to the high mutation rate of RNA replication, which often leads to the generation of quasispecies virus populations (Holland et al., 1992) . These quasispecies populations interact with each other, and contribute to the virus's adaptation to new environments during virus replication (Domingo & Holland, 1997; Vignuzzi et al., 2006) . One crucial mechanism of the high mutation rate for RNA viruses is the low fidelity of RNA-dependent RNA polymerase (RdRp) due to its lack of proofreading ability during RNA replication (Domingo & Holland, 1997; Smith et al., 2013) . Studies of poliovirus and other RNA viruses revealed that certain amino acid residues in RdRp are fidelity checkpoints which affect the fidelity of RdRp, and that the fidelity of RdRp can be modulated by change of these checkpoint residues (Gnädig et al., 2012; Rozen-Gagnon et al., 2014; Sadeghipour et al., 2013; Vignuzzi et al., 2008; Zeng et al., 2014) . Mutants carrying a high fidelity RdRp showed a decreased population quasispecies diversity and attenuated pathogenicity to hosts (Van Slyke et al., 2015) . Therefore, high fidelity virus mutants could serve as potential safer modified live-attenuated vaccines (MLVs) for RNA viruses (Vignuzzi et al., 2008) .
Porcine reproductive and respiratory syndrome virus (PRRSV), an economically important swine pathogen, is a positive-sense ssRNA virus. As a member of the family Arteriviridae, the genome of PRRSV comprises a large replicase gene (ORF1a and ORF1b) (Fang & Snijder, 2010) . Nonstructural protein 9 (nsp9), one of the products encoded by ORF1b, possesses RdRp activity that plays a crucial role in virus genomic replication (Beerens et al., 2007; Zhou et al., 2011) . The PRRSV genome has an extremely high mutation rate which is estimated to be approximately 10 22 per site year
21
, higher than any of the other known RNA viruses (10 23 -10 25 per site year
) (Hanada et al., 2005; Murtaugh et al., 2010) . Therefore, the current PRRSV MLVs have a potential risk of reversion to the virulent phenotype, and may also recombine with field strains to generate new variant strains (Kimman et al., 2009; Lu et al., 2015; Martín-Valls et al., 2014) . Therefore, MLVs with a more stable virus genome are desired.
In this study, we aim to identify the checkpoint amino acid residues in RdRp of PRRSV that play a crucial role in the fidelity of PRRSV replication. To achieve this objective, two different strains of PRRSV, strain VR2385 (GenBank accession no. JX044140) and strain MN184B (GenBank accession no. DQ176020), were consecutively passaged each in MARC-145 cells under the selection of ribavirin, which has been successfully used to screen high fidelity virus mutants in vitro by increasing the mutation frequency of RNA viruses above the point of error catastrophe, ultimately driving quasispecies with low fidelity RdRp into extinction (Crotty et al., 2000; Pfeiffer & Kirkegaard, 2003; Sadeghipour et al., 2013; Zeng et al., 2014) .
We first optimized the concentration of ribavirin used in the serial virus passages. We showed that cell viability in the presence of ribavirin did not significantly decrease compared to that of the mock control cells without ribavirin, even at a concentration up to 1600 mM (Fig. 1a) . . PRRSV strain VR2385 (c) and strain MN184B (d) were consecutively passaged to P20 in the presence (+Rb) or absence (2Rb) of 200 mM ribavirin. The P5, P10, P15 and P20 viruses were each assayed by a ribavirin resistance assay. The ribavirin resistance ratio was calculated as the viral titre (log 10 TCID 50 ml 21 ) with ribavirin (200 or 400 mM) divided by the viral titre without ribavirin (0 mM). For all assays, three independent repeats were performed. Mean values¡SEM are shown. An unpaired twotailed Student's t-test was used to evaluate the statistical significance of differences between +Rb and 2Rb samples at 200 or 400 mM ribavirin at certain passage number (* P,0.05, ** P,0.01, *** P,0.001).
When PRRSV strain VR2385 was passaged in the presence of ribavirin at 50 or 100 mM, there was no significant viral titre decrease, while at 400 or 800 mM, the virus populations were extinguished after two or three rounds of passage (Fig. 1b) . The results indicated that PRRSV is highly sensitive to ribavirin, since it accumulates more lethal mutations by mistakenly incorporating ribavirin. For other RNA viruses, it has been reported that poliovirus can tolerate consecutive in vitro passages at 600 mM ribavirin, foot-mouth disease virus (FMDV) at 800 mM, and human enterovirus 71 at 1600 mM (Sadeghipour et al., 2013; Sierra et al., 2007; Vignuzzi et al., 2006) . The high sensitivity of PRRSV to ribavirin suggested a potential usage as an antiviral to inhibit PRRSV infection (Kim & Lee, 2013) . Based on the above results, we selected the 200 mM concentration of ribavirin for serial passaging of PRRSV in this study.
The two different PRRSV strains were serially passaged for 20 passages (P20) with (+Rb) or without (2Rb) 200 mM ribavirin. Fresh MARC-145 cells were pretreated with ribavirin at a concentration of 200 mM for 1 h. The cells were then washed twice and incubated with PRRSV strains at an m.o.i. of 0.1. After 1 h incubation, the cells were washed, after which low glucose-supplemented Dulbecco's Minimal Essential Medium (DMEM) with 2 % FBS containing 200 mM ribavirin was added. At 72 (for VR2385) or 96 (for MN184B) h post-infection (h p.i.), the supernatants were harvested and titrated as described elsewhere for the next round of passage (Tian et al., 2012) .
The viruses from passages P5, P10, P15 and P20 were used to monitor the frequency of ribavirin resistance in virus populations, using a ribavirin resistance assay which has been described elsewhere (Sadeghipour et al., 2013) . MARC-145 cells were pretreated with ribavirin at final concentrations of 0, 200 or 400 mM, respectively. After 1 h incubation with viruses at an m.o.i. of 0.1, cells were washed and then maintained in 2 % FBS DMEM with 0, 200 or 400 mM ribavirin, respectively. At 72 (VR2385) or 96 (MN184B) h p.i., the supernatants were harvested and titrated. The ratio of ribavirin resistance frequency was calculated as the viral titre (log 10 TCID 50 ml
) with ribavirin (200 or 400 mM) divided by the titre without ribavirin (0 mM). As shown in Fig. 1(c) , in the ribavirin resistance assay at a concentration of 200 mM ribavirin, the ratios of ribavirin resistance correlated with the virus serial passage numbers. The ratios for ribavirin-selected viruses (+Rb) were significantly higher than those for nonribavirin-selected viruses (2Rb) at P15 and P20. To further monitor the increasing ribavirin resistance, we also tested the ratios at a concentration of 400 mM ribavirin, and obtained similar results (Fig. 1c) . In a parallel experiment, similar results were obtained with another PRRSV strain, MN184B (Fig. 1d) . The results demonstrated that PRRSV populations with an increased resistance to ribavirin were generated. The ribavirin-selected P20 virus of PRRSV strain VR2385 was isolated by three rounds of plaque purifications, and designated as VR2385R.
To identify the amino acid mutation(s) in nsp9 that are involved in conferring resistance to ribavirin in PRRSV populations, the nsp9 coding regions of the P10 and P20 viruses of PRRSV strains VR2385 and MN184B were amplified by reverse transcription (RT)-PCR using a high fidelity SuperScript III One-step RT-PCR kit (Invitrogen). The amplified products were cloned using a Zero Blunt TOPO PCR Clone kit (Invitrogen) for Sanger sequencing. The consensus sequences were generated from 6-10 clones. Sequence comparison between ribavirin-selected and non-ribavirin-selected viruses revealed that all nucleotide mutations were transitions (GRA, CRU), and only one of these nucleotide mutations actually led to an amino acid change in PRRSV VR2385 (421: HisRTyr, 'H421Y') and in PRRSV MN184B (283: AlaRThr, The P3 reconstituted viruses were used, and three independent assays were performed. Mean values¡SEM are shown. The differences were compared between the parental PRRSV VR2385, and reconstituted viruses or VR2385R at 200 or 400 mM ribavirin. Statistical significance was determined using unpaired two-tailed Student's t-test (* P,0.05, ** P,0.01). (e) The total variant numbers of mutant nucleotides of ORF5 in viral populations (Fig. S1 ) as detected by deep sequencing when compared to the parental reference ORF5 sequence (accession no. JX044140). The background noise caused by sequencing error was determined to be 0.1 %.
'A283T'), respectively (Fig. 2a) . However, these amino acid mutations did not occur in the P10 viruses (Fig. 2b, c) . This was consistent with the observation that the populations acquired increased ribavirin resistance at certain passages between P10 and P15 (Fig. 1c, d ).
The nsp9 sequences of other PRRSV strains, including genotype 2 strains from different isolation years, geographical positions, pathogenicity, and available MLVs, as well as five genotype 1 strains, were aligned (Fig. 2d) . The sequence alignment data showed that the residue His421 identified in PRRSV VR2385 was conserved in all selected genotype 2 PRRSVs, and residue Ala283 identified in PRRSV MN184B was conserved in all selected PRRSV strains. Therefore, the above results suggested that the two amino acid mutations (H421Y and A283T) identified in ribavirin-selected PRRSV strains were involved in conferring an increased ribavirin resistance property.
To further verify that the amino acid mutations (H421Y and A283T) in nsp9 of PRRSV were involved in conferring ribavirin resistance, the two amino acid mutations were individually or in combination introduced into the backbone of an infectious clone of PRRSV, pIR-VR2385-CA, which was constructed based on the PRRSV strain VR2385 (Ni et al., 2011) . The recombinant clones containing the introduced mutation(s) were used to transfect fresh MARC-145 cells using a Lipofectamine LTX and Plus Reagent kit (Invitrogen) according to the manufacturer's instructions.
The rescued reconstituted viruses, vA283T (containing the A283T substitution), vH421Y (H421Y), and vTY (A283T and H421Y), were all viable as evidenced by indirect immunofluorescence assay (IFA) stained with anti-PRRSV nucleocapsid (N) protein monoclonal antibody SDOW17 (Rural Technologies) (Fig. 3a) . Passage 3 of the reconstituted viruses, as well as passage 3 of the WT parental VR2385 virus, as well as VR2385R, were used for virological characteristic analyses as described elsewhere (Tian et al., 2012) . The reconstituted viruses, H421Y and vTY, as well as VR2385R, displayed lower viral peak titres than parental virus VR2385 (Fig. 3b) , and all reconstituted viruses produced smaller plaques compared to the parental virus (Fig. 3c) . This indicated that the amino acid substitutions in nsp9 affected PRRSV fitness in vitro, a characteristic which was usually observed in some other RNA virus mutants containing high fidelity RdRp (Coffey et al., 2011; Van Slyke et al., 2015) .
The ribavirin resistance assay showed that the reconstituted viruses vA283T and vTY, as well as VR2385R, have a significant increase in the ribavirin resistance ratio compared to that of the parental PRRSV VR2385 at a concentration of 200 mM ribavirin, while vH421Y has only a numerical increase that was not statistically significant (Fig. 3d) . At a concentration of 400 mM ribavirin, vA283T and VR2385R also showed a significant increase, while vH421Y and vTY showed only a numerical increase (Fig. 3d) . This further suggested that the two amino acid substitutions in nsp9 conferred PRRSV with resistance to ribavirin.
To determine the stability of the amino acid substitutions in the mutants, the mutant viruses were serially passaged to P8 in vitro in the absence of ribavirin. The target positions of P3 and P8 viruses were sequenced. Sequence analyses revealed that the amino acid substitutions were stable for at least eight serial passages (Fig. 2b, c) .
According to the findings on poliovirus and other RNA viruses, ribavirin-resistant viral populations have increased RdRp fidelity during RNA replication which leads to a lower quasispecies sequence diversity. To determine if the ribavirin-resistant PRRSVs generated in this study possess a restricted quasispecies diversity, ORF5 of PRRSV was analysed, largely because ORF5 is one of the most variable structural protein genes. One of the approaches used to determine the sequence diversity is RT-PCR amplification followed by traditional cloning and Sanger sequencing. This approach is straightforward, but the data are usually restricted by the limited numbers of sequenced clones. To determine the sequence diversity more comprehensively, we performed deep-sequencing of ORF5 by generation of millions of reads. Amplicons containing 549 bp from the N terminus of ORF5 were amplified by RT-PCR from viral genomes, using a high fidelity SuperScript III One-step RT-PCR kit. Approximately 500 ng of DNA was converted to Illuminacompatible libraries using Illumina's TruSeq DNA PCRFree LY Library Prep kit according to the manufacturer's instructions. Individual libraries were pooled in equal molar amounts, denatured and loaded onto a MiSeq at 11.5 pM with 5 % phiX. The pooled libraries were sequenced to 26250 PE on the MiSeq to obtain 12-15 million reads using Illumina's MiSeq Reagent kit. Following sequencing, the data were trimmed for both adaptor and quality using a combination of ea-utils and Btrim (Kong, 2011) . Sequencing reads were then aligned to the ORF5 of PRRSV VR2385 (accession no. JX044140) using Tophat2 (Langmead & Salzberg, 2012) . Variants were called using a combination of Samtools PILEUP (version 0.1.16) and VarScan2 (Koboldt et al., 2012; Li et al., 2009 ).
The analysis of deep sequencing results showed that most of the nucleotide variants occurred at a frequency between 0.1 % and 1 % (Fig. S1 , available in the online Supplementary Material). Compared with the parental PRRSV VR2385 (189 variants), the purified ribavirin-selected VR2385R (161) and reconstituted mutants vA283T (121), vH421Y (157) and vTY (160) generated fewer variant nucleotides, indicating that amino acid substitutions of A283T and H421Y in nsp9 led to a restricted quasispecies diversity during PRRSV replication (Fig. 3e) . Interestingly, the combined substitutions virus vTY did not show the lowest quasispecies diversity as expected. Whether a different RNA proofreading mechanism was involved in PRRSV replication fidelity remains unknown but is beyond the scope of this present study (Smith et al., 2013) .
Only one amino acid residue substitution (G64S) was previously identified in poliovirus which conferred resistance to ribavirin and decreased quasispecies diversity (Pfeiffer & Kirkegaard, 2003; Vignuzzi et al., 2006) . In this study, two different amino acid substitutions were identified, each from a different PRRSV strain, which also occurred in some other RNA viruses. For example, by using different strains of FMDV, one study identified one substitution (M296I) while other independent studies identified three (P44S, P169S and M296I) or four (D5N, A38V, M194I and M296V) different substitutions that confer resistance to ribavirin and increased fidelity (Agudo et al., 2010; Sierra et al., 2007; Zeng et al., 2014) . A couple of amino acid mutations were also identified in coxsackievirus B3 virus, human enterovirus 71 virus and bovine viral diarrhea virus (Curti & Jaeger, 2013; Gnädig et al., 2012; Sadeghipour et al., 2013) . For the two amino acid substitutions identified in PRRSV in this study, when they were introduced into the PRRSV VR2385 infectious clone backbone, the rescued reconstituted virus vA283T showed a more ribavirin-resistant profile and fewer quasispecies variants than the other reconstituted virus vH421Y (Fig. 3d, e) . We also found that the residue Ala283 is more conserved than His421: Ala283 is conserved among both type 1 and type 2 PRRSV strains, whereas His421 is conserved only among type 2 PRRSV strains (Fig. 2d) . Therefore, it is reasonable to speculate that the substitution of A283T plays a more important role in conferring high fidelity.
It is known that viral pathogenesis is correlated with quasispecies diversity (Holland et al., 1992; Van Slyke et al., 2015; Vignuzzi et al., 2006) . The genetic determinants of PRRSV virulence remain controversial, and one research group reported the importance of nsp9 and nsp10 in PRRSV virulence . PRRSV strains with lower quasispecies diversity generated in this study may be less virulent than the WT, and thus could potentially be viable candidates for developing more stable and safe MLVs.
In summary, we identified two amino acid residues in the nsp9 of PRRSV that are involved in conferring ribavirin resistance and restricting the quasispecies diversity profile. This finding will help us further understand the molecular mechanisms of PRRSV evolution and pathogenesis, and aid in the development of safer PRRSV MLVs.
